Ulrich Mey
- Hematology top 1%
- Multiple Myeloma Research and Treatments 11
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 17
-
- Lymphoma Diagnosis and Treatment 25
- Oncology top 2%
- Viral-associated cancers and disorders 12
- Neutropenia and Cancer Infections 9
- Cancer Treatment and Pharmacology 6
- Family Practice top 5%
-
- Protein Degradation and Inhibitors 8
-
- CNS Lymphoma Diagnosis and Treatment 5
- Co-authors
- Ingo G.H. Schmidt‐WolfCarsten ZiskeMarcus GorschlüterAxel GlasmacherJohn StrehlTilman SauerbruchIngo Schmidt‐WolfPhilippe Moreau
- Journals
- Supportive Care in Cancer (7 papers)Swiss Medical Weekly (6 papers)Annals of Oncology (4 papers)
- Partner nations
- GermanySwitzerlandItaly
In The Last Decade
Ulrich Mey
66 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Hematology 854
- Genetics 769
- Pathology and Forensic Medicine 1.0k
- Oncology 1.5k
- Family Practice 71
Countries citing papers authored by Ulrich Mey
This map shows the geographic impact of Ulrich Mey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrich Mey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrich Mey more than expected).
Fields of papers citing papers by Ulrich Mey
This network shows the impact of papers produced by Ulrich Mey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrich Mey. The network helps show where Ulrich Mey may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ulrich Mey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†breakdown → | 2021 | 460 |
| 3 | 2017 | 10 | |
| 4 | 2015 | 4 | |
| 5 | 2013 | 2 | |
| 6 | 2013 | 18 | |
| 7 | 2010 | 2 | |
| 8 | 2010 | 108 | |
| 9 | 2009 | 6 | |
| 10 | 2008 | 13 | |
| 11 | 2008 | 2 | |
| 12 | 2007 | 371 | |
| 13 | High dose chemotherapy with autologous stem cell transplantation in diffuse large B-cell lymphoma | 2007 | 2 |
| 14 | 2007 | 7 | |
| 15 | 2006 | 26 | |
| 16 | 2004 | 10 | |
| 17 | 2003 | 15 | |
| 18 | 2003 | 136 | |
| 19 | 2003 | 30 | |
| 20 | 2002 | 39 |
About Ulrich Mey
Ulrich Mey is a scholar working on Genetics, Oncology and Hematology, having authored 68 papers that have together received 2.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (25 papers), Chronic Lymphocytic Leukemia Research (17 papers), Viral-associated cancers and disorders (12 papers), Multiple Myeloma Research and Treatments (11 papers), Neutropenia and Cancer Infections (9 papers), Protein Degradation and Inhibitors (8 papers), Cancer Treatment and Pharmacology (6 papers) and CNS Lymphoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Hematology (854 citations), Genetics (769 citations) and Pathology and Forensic Medicine (1.0k citations). Ulrich Mey has collaborated with scholars based in Germany, Switzerland and Italy. Frequent co-authors include Ingo G.H. Schmidt‐Wolf, Carsten Ziske, Marcus Gorschlüter, Axel Glasmacher, John Strehl, Tilman Sauerbruch, Ingo Schmidt‐Wolf, Philippe Moreau, Roman Hájek and Hermann Einsele. Their work appears in journals such as Supportive Care in Cancer, Swiss Medical Weekly, Annals of Oncology, Journal of Clinical Oncology and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.